Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Cardiology Clinical Trials
CETP Inhibitor Evacetrapib Reduces LDL-C and Raises HDL-C Levels
AIM-HIGH: Niacin Provides No Added Benefit for Statin Users with Well-Controlled LDL
BRIDGE Study Demonstrates Feasibility and Safety of Cangrelor
TAVI Improves QoL in Patients Suitable for Transfemoral TAVI
Results from the PARTNER Trial (Cohort A): Transfemoral TAVI Economically Attractive but Transapical TAVI More Costly
PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years
Benefits of Apixaban over Warfarin are Consistent, Irrespective of TTR
Safety and Tolerability Darexaban in Patients with ACS: The RUBY-1 Trial
EMPHASIS-HF: An Analysis of the High-Risk Groups
PURE: CV Drugs Underused for Secondary Prevention in Poor and Rural Populations
Pages
Previous
Next
1
…
26
27
28
29
30
31
32
33
34
…
38
